ADAR1 Capital Management, LLC
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 92% of reported value on average across 10 quarters. Past performance does not predict future results.
Portfolio Concentration
284 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 95.2% | $1,532,497,104 |
| Unclassified | 3.1% | $49,386,819 |
| Financial Services | 1.3% | $20,854,064 |
| Industrials | 0.1% | $1,392,592 |
| Technology | 0.1% | $1,367,627 |
| Basic Materials | 0.1% | $1,296,600 |
| Communication Services | 0.1% | $1,006,302 |
| Real Estate | 0.1% | $905,190 |
| Consumer Cyclical | 0.0% | $744,595 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVR | Anteris Technologies Global Corp. | +2,550,355 | 3,789,132 | $21,029,682 | |
| PLRX | Pliant Therapeutics, Inc. | +2,511,307 | 2,585,126 | $3,257,258 | |
| DNLI | Denali Therapeutics Inc. | +1,819,339 | 1,871,455 | $35,931,936 | |
| IRD | Opus Genetics, Inc. | +1,809,004 | 1,849,004 | $8,412,968 | |
| PEPG | PepGen Inc. | +1,570,796 | 1,607,638 | $2,845,519 | |
| OKUR | OnKure Therapeutics, Inc. | +1,420,783 | 2,434,941 | $10,080,655 | |
| ABOS | Acumen Pharmaceuticals, Inc. | +1,265,151 | 2,156,334 | $5,088,948 | |
| SPRY | ARS Pharmaceuticals, Inc. | +991,967 | 1,361,536 | $10,933,134 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +829,963 | 1,139,331 | $41,380,501 | |
| VYNE | VYNE Therapeutics Inc. | +810,108 | 1,063,899 | $636,211 | |
| CATX | Perspective Therapeutics, Inc. | +654,142 | 749,335 | $3,124,726 | |
| TERN | Terns Pharmaceuticals, Inc. | +573,084 | 1,114,699 | $58,766,931 | |
| TSHA | Taysha Gene Therapies, Inc. | +483,620 | 2,979,429 | $13,318,047 | |
| STRO | Sutro Biopharma, Inc. | +457,364 | 524,441 | $13,063,825 | |
| RLMD | Relmada Therapeutics, Inc. | +421,052 | 451,918 | $3,145,349 | |
| REPL | Replimune Group, Inc. | +416,665 | 1,682,987 | $12,874,850 | |
| INSP | Inspire Medical Systems, Inc. | +390,197 | 405,197 | $20,900,061 | |
| SRRK | Scholar Rock Holding Corp | +337,684 | 407,273 | $20,021,540 | |
| LONA | LeonaBio, Inc. | +333,780 | 727,481 | $7,478,504 | |
| SYRE | Spyre Therapeutics, Inc. | +304,272 | 338,323 | $17,065,012 | |
| ELVN | Enliven Therapeutics, Inc. | +299,540 | 329,540 | $12,917,968 | |
| KPTI | Karyopharm Therapeutics Inc. | +291,936 | 341,936 | $1,904,583 | |
| PALI | Palisade Bio, Inc. | +260,000 | 2,264,845 | $3,963,478 | |
| OVID | Ovid Therapeutics Inc. | +259,113 | 4,544,113 | $10,087,930 | |
| SNY | Sanofi | +253,465 | 316,939 | $15,270,121 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | −2,281,934 | 3,133,175 | $14,099,287 | |
| EQ | Equillium, Inc. | −1,881,419 | 3,726,659 | $7,453,318 | |
| IKT | Inhibikase Therapeutics, Inc. | −1,457,377 | 6,606,572 | $11,099,040 | |
| FULC | Fulcrum Therapeutics, Inc. | −1,188,189 | 130,560 | $1,001,395 | |
| CTMX | CytomX Therapeutics, Inc. | −872,579 | 3,410,190 | $16,027,893 | |
| ELDN | Eledon Pharmaceuticals, Inc. | −847,391 | 974,421 | $3,001,216 | |
| CLYM | Climb Bio, Inc. | −834,813 | 597,662 | $4,093,984 | |
| CBIO | Crescent Biopharma, Inc. | −555,727 | 50,273 | $923,515 | |
| IVA | Inventiva S.A. | −535,448 | 2,174,398 | $12,067,908 | |
| ACRS | Aclaris Therapeutics, Inc. | −481,560 | 132,426 | $496,597 | |
| GOSS | Gossamer Bio, Inc. | −423,300 | 287,531 | $94,597 | |
| CRVS | Corvus Pharmaceuticals, Inc. | −377,974 | 87,901 | $1,285,991 | |
| AQST | Aquestive Therapeutics, Inc. | −244,000 | 10,000 | $41,500 | |
| CLDX | Celldex Therapeutics, Inc. | −218,951 | 427,816 | $13,570,323 | |
| HELP | Cybin Inc. | −207,112 | 31,278 | $150,134 | |
| TARA | Protara Therapeutics, Inc. | −196,287 | 940,512 | $4,900,067 | |
| ENGN | enGene Therapeutics Inc. | −170,000 | 133,686 | $910,401 | |
| ROIV | Roivant Sciences Ltd. | −143,056 | 3,285,906 | $91,019,596 | |
| GERN | Geron Corp | −136,176 | 200,000 | $298,000 | |
| LRMR | Larimar Therapeutics, Inc. | −132,944 | 52,745 | $237,352 | |
| MAZE | Maze Therapeutics, Inc. | −129,437 | 50,095 | $1,495,335 | |
| BBIO | BridgeBio Pharma, Inc. | −119,122 | 94,292 | $7,002,123 | |
| RGNX | REGENXBIO Inc. | −100,432 | 44,416 | $372,206 | |
| INO | Inovio Pharmaceuticals, Inc. | −90,400 | 1,470,108 | $2,557,987 | |
| TNGX | Tango Therapeutics, Inc. | −90,021 | 50,000 | $1,046,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | 1,446,375 | $34,467,116 | |
| VIR | Vir Biotechnology, Inc. | 2,744,714 | $24,592,637 | |
| DBVT | DBV Technologies S.A. | 1,012,866 | $21,158,770 | |
| HLXC | Helix Acquisition Corp. III | 1,000,000 | $10,160,000 | |
| MLTX | MoonLake Immunotherapeutics | 477,137 | $8,893,833 | |
| MPLT | MapLight Therapeutics, Inc. | 374,909 | $7,621,899 | |
| DMRA | Damora Therapeutics, Inc. | 279,000 | $7,226,100 | |
| PRME | Prime Medicine, Inc. | 1,973,282 | $6,867,021 | |
| KRRO | Korro Bio, Inc. | 540,054 | $6,113,411 | |
| INSM | INSMED Inc | 35,392 | $5,787,299 | |
| LLY | ELI LILLY & Co | 5,060 | $4,654,036 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 55,000 | $4,615,600 | |
| ONC | BeOne Medicines Ltd. | 11,701 | $3,474,845 | |
| AVBP | ArriVent BioPharma, Inc. | 141,814 | $3,271,648 | |
| ATAI | AtaiBeckley Inc. | 913,242 | $3,232,876 | |
| CAPR | Capricor Therapeutics, Inc. | 90,593 | $2,754,027 | |
| CNTB | Connect Biopharma Holdings Ltd | 742,400 | $1,945,088 | |
| NVO | Novo Nordisk A S | 46,000 | $1,690,500 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 105,000 | $1,518,300 | |
| UNH | Unitedhealth Group Inc | 5,501 | $1,488,515 | |
| SXT | Sensient Technologies Corp | 15,000 | $1,296,600 | |
| MSLE | Satellos Bioscience Inc. | 222,555 | $1,252,984 | |
| PMN | ProMIS Neurosciences Inc. | 95,350 | $1,210,945 | |
| LXRX | Lexicon Pharmaceuticals, Inc. | 750,000 | $1,170,000 | |
| SDGR | Schrodinger, Inc. | 101,500 | $1,153,040 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 226,248 | $2,832,624 | |
| GRCE | Grace Therapeutics, Inc. | 641,988 | $2,221,278 | |
| OLMA | Olema Pharmaceuticals, Inc. | 81,399 | $2,034,975 | |
| OMER | Omeros Corp | 100,000 | $1,718,000 | |
| UTHR | UNITED THERAPEUTICS Corp | 1,900 | $925,775 | |
| QNRX | Quoin Pharmaceuticals, Ltd. | 58,230 | $840,258 | |
| NGNE | Neurogene Inc. | 30,633 | $631,039 | |
| NVCR | NovoCure Ltd | 34,000 | $439,620 | |
| AUPH | Aurinia Pharmaceuticals Inc. | 22,000 | $350,900 | |
| IDXX | Idexx Laboratories Inc /De | 400 | $270,612 | |
| SPRO | Spero Therapeutics, Inc. | 113,839 | $265,244 | |
| OTLK | Outlook Therapeutics, Inc. | 100,000 | $158,000 | |
| ZONE | CleanCore Solutions, Inc. | 521,980 | $135,714 | |
| SABS | SAB Biotherapeutics, Inc. | 26,344 | $98,526 | |
| IVF | INVO Fertility, Inc. | 26,722 | $20,121 | |
| IOBTQ | IO Biotech, Inc. | 24,964 | $15,203 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
CALL
+ SHARES
Healthcare
|
Added | 1,438,019 | $160,123,415 | 9.95% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 994,119 | $104,780,142 | 6.51% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 3,285,906 | $91,019,596 | 5.66% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 2,679,010 | $66,546,608 | 4.13% | |
| TERN |
Terns Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Added | 1,114,699 | $58,766,931 | 3.65% | |
| SPY |
Spdr S&P 500 ETF Trust
|
Added | 75,940 | $49,386,819 | 3.07% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 632,556 | $41,691,765 | 2.59% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 1,139,331 | $41,380,501 | 2.57% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 1,871,455 | $35,931,936 | 2.23% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
NEW | 1,446,375 | $34,467,116 | 2.14% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 1,425,367 | $26,811,153 | 1.67% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Reduced | 1,089,818 | $26,188,326 | 1.63% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
NEW | 2,744,714 | $24,592,637 | 1.53% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
NEW | 1,012,866 | $21,158,770 | 1.31% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Added | 3,789,132 | $21,029,682 | 1.31% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Added | 405,197 | $20,900,061 | 1.30% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 407,273 | $20,021,540 | 1.24% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 211,450 | $18,389,806 | 1.14% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Added | 338,323 | $17,065,012 | 1.06% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Reduced | 3,410,190 | $16,027,893 | 1.00% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Added | 1,581,443 | $15,371,625 | 0.96% | |
| SNY |
Sanofi
Healthcare
|
Added | 316,939 | $15,270,121 | 0.95% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 259,137 | $15,058,451 | 0.94% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Added | 264,278 | $14,479,791 | 0.90% | |
| ABUS |
Arbutus Biopharma Corp
Healthcare
|
Reduced | 3,133,175 | $14,099,287 | 0.88% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 1,000,604 | $13,908,395 | 0.86% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 427,816 | $13,570,323 | 0.84% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 2,979,429 | $13,318,047 | 0.83% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 228,899 | $13,310,476 | 0.83% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 524,441 | $13,063,825 | 0.81% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 133,893 | $13,021,094 | 0.81% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 329,540 | $12,917,968 | 0.80% | |
| REPL |
Replimune Group, Inc.
CALL
+ SHARES
Healthcare
|
Added | 1,682,987 | $12,874,850 | 0.80% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 185,699 | $12,568,108 | 0.78% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Added | 213,473 | $12,120,996 | 0.75% | |
| IVA |
Inventiva S.A.
Healthcare
|
Reduced | 2,174,398 | $12,067,908 | 0.75% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 160,338 | $12,039,780 | 0.75% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 161,252 | $11,602,081 | 0.72% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Reduced | 6,606,572 | $11,099,040 | 0.69% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Added | 1,361,536 | $10,933,134 | 0.68% | |
| HLXC |
Helix Acquisition Corp. III
Financial Services
|
NEW | 1,000,000 | $10,160,000 | 0.63% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Reduced | 4,544,113 | $10,087,930 | 0.63% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Added | 2,434,941 | $10,080,655 | 0.63% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 12,154 | $9,390,666 | 0.58% | |
| MLTX |
MoonLake Immunotherapeutics
CALL
+ SHARES
Healthcare
|
NEW | 477,137 | $8,893,833 | 0.55% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 1,467,350 | $8,422,589 | 0.52% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
Added | 1,849,004 | $8,412,968 | 0.52% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
Added | 268,391 | $8,083,936 | 0.50% | |
| SVRA |
Savara Inc
Healthcare
|
Added | 1,464,535 | $7,996,361 | 0.50% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
NEW | 374,909 | $7,621,899 | 0.47% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.